Edwards Lifesciences (EW) Change in Cash (2009 - 2026)

Edwards Lifesciences has reported Change in Cash for 18 years, with the latest figure at $462.2 million in Q2 2026.

• On a quarterly basis, Change in Cash rose 227.34% year-over-year to $462.2 million in Q2 2026; TTM through Jun 2026 was -$380.3 million, a 123.3% decrease from a year earlier, with the FY2025 full-year figure at -$119.3 million, down 106.24% from the prior year.
• Change in Cash was $462.2 million for Q2 2026 at Edwards Lifesciences, up from -$492.0 million in the prior quarter.
• The five-year high for Change in Cash was $2.0 billion in Q3 2024, with the low at -$624.6 million in Q4 2024.
• Average Change in Cash over 5 years is $113.5 million, with a median of $122.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Change in Cash soared 1905.38% in 2022, then plunged 646.67% in 2026.
• Over 5 years, Change in Cash stood at -$479.1 million in 2022, then jumped by 44.5% to -$265.9 million in 2023, then plunged by 134.9% to -$624.6 million in 2024, then jumped by 139.18% to $244.7 million in 2025, then soared by 88.88% to $462.2 million in 2026.
• The last three Change in Cash figures came in at $462.2 million (Q2 2026), -$492.0 million (Q1 2026), and $244.7 million (Q4 2025), per Business Quant data.